fulranumab

Pfizer Steps Out Of Johnson & Johnson's Shadow To Get A Tan
Seeking Alpha
Mon, 04/11/16 - 05:20 pm
Pfizer
JNJ
fulranumab
tanezumab
anti-NGF
painkillers
That blockbuster anti-NGF pain drug fulranumab? J&J doesn't want it anymore
Fierce Biotech
Fri, 04/1/16 - 10:10 am
JNJ
fulranumab
anti-NGF
painkillers
Amgen
U.S. Regulators Probes Resuming Painkiller Trials Tied to Joint Failure
Bloomberg
Thu, 03/8/12 - 09:55 am
Pfizer
JNJ
FDA
joint failure
painkillers
fulranumab
Sanofi
Regeneron
tanezumab
REGN475/SAR164877